This data-based intelligencer will continue to be updated based on new financial documents so that readers can stay modern. Companies must submit with SEC or SEDAR and be modern to be considered for inclusion. When we started this resource in May 2019, quarterly-income companies, more than $ 2.5 million. As the industry has received a scale, since more companies have published, we later raised the minimum, including $ 12.5 million on September 2020. $ 50 million ($ 68.8 million), and the junior list now has at least $ 25 million ($ 34.4 million).
Note about regulated operating income
In May 2019 we added an additional meter, “adjusted operating income” We detailed In our news. The calculation takes the reported operating income and adjusts it for any change in the real value of biological assets required under IFRS accounting. We believe that this adjustment improves the comparison of companies in IFRS and NAS accounting. We note that frequently income can include one-time compensation, inventory writing or public listing costs, and we recommend that readers understand this unterior materials on quarterly finance. Many companies have been transferred from ITMS to NAS Account, which reduced our need to make adjustments. Please note that our ranking includes only actual reported income and not Pro Forma IncomeWe also note that companies with non-Cannabis actions should provide financial statements in the level of sector, which details not only income, but also operating profits, which must have their operating profits. Aurora Canepis is currently (TSX: ACB), Jazz Pharma (NASDAQ: JH) and TILRAY (TSX: TLRY) does not provide this information.
Tracker Inclusion Updates:
On July 27, at the time of our latest update, 16 companies are qualified for the inclusion of senior lists, including $ 13 and 3 in Canadian currency and 3 have had 13 companies. Currently, 13 companies presenting US dollars and 3 that file in Canadian dollars are the Senior lists, 16 in total. The younger list includes 11 companies that make 11 companies in Canadian dollars. The income of the public Cannabis and the income search engine now includes 29 companies. One company, farmland (NASDAQ. In Canada, both junior list names, canopy growth and organ have moved to a senior list.
Companies were reported to be reported in late July
Since our latest update, almost all Armenian companies have announced their June quarterly reports.
Senior and Junior – US Dollar Report
All recently reported all five MSOS, and the results were not particularly impressive. Curaleaf (OTC: Curlf) (TSX: Cura) has saved the income leader, which decreased by 8% a year ago. Thuelieve (OTC: TCNNF) (CSE: TRUL) saw the income unchanged a year ago. Green Thumb Industries (OTC: GTBIF) (CSE: GTII) has experienced an income that increased by 5% compared to the previous year, but operating profits were sharply dipped. Verano Holdings (OTC: VRNOF) (NEO: VRNO) MSOS was 4th place in MSOS, but its income fell a year ago. CRESCO LABS (OTC: CRLBF) (CSE: CL) had the largest biggest MSOS downfall.
Looking ago, all senior list companies reported, although there are several companies in the junior list that have not yet been submitted. Before mid-November, none of the 5 largest MSOs provided for their Q3 financial statements, but here are the current prospect by Learn:
Curaleaf (OTC: Curlf) (TSX: Cura) – Revenues will drop from 4% to 317.2 million dollars, $ 10%
Thuelieve (OTC: TCNNF) (CSE:
Green Thumb Industries (OTC: GTBII) (CSE: GTII) – Revenues are expected to increase by 1% by 291.0 million dollars, 82.3 million dollars
Verano Holdings (OTC: VRNOF) (Neo: VRNO) – Revenues will be reduced from 6% to $ 203.1 million, with an Ebitda, 6% to $ 60.6 million
Cresco Labs (OTC: CLBF) (CSE: CL) – Revenues will be reduced by 9% to $ 163.8 million adjusted eBitda, decreased by $ 36.7 million
Senior and Junior – Canadian Dollar Report
Nipple (NASDAQ: SNDL) (CSE: SNDL) is possible cannabis income and a year ago. Aurora hemp (NASDAQ. ACB) (TSX: ACB) The revenues seen again a year ago, but slipped successively. Canopy (NASDAQ. CGC) (TSX. Weed) had a great operational loss, although it was a decline a year ago. Organic global (NASDAQ. OGI) (TSX. OGI) has shown a large increase in revenue that stimulates achievements.
Currently, there are still calls for senior companies.
Cannabis Cannabis Revenue Tracker is not a proposal by New Cannabis Ventures, and you should not use it as investment advice. Tilde next to the date means an approximate date. All calculations come from sec or sedar files. For any question or licensing requests please Contact usA number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Statistics Canada released September retail sales for the country, with Cannabis sales are on the rise from August levels, down 1.4% to C$475.0 million. This sequential decline increased on a daily basis due to fewer days compared to the previous month. August, originally reported at C$498.7 million, was revised slightly higher to C$503.1 million. Sales rose 6.6% in September from a year earlier, up from 8.3% in May and 7.5% in June. This was also below the 20.3% growth rate in August 2023 and above the previous lowest annual growth since the start of legalization in September 2024 of -0.9%, and it was significantly down from the 9.1% growth in December. In August, the record growth was only 1.8% higher than the index of the previous year. Total sales grew by 4.5% to C$5.39 billion in 2024 and 4.9% year-to-date in 2025.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales fell 5.0% from August and less than 1% from a year ago. Alberta was down 5.5% from August and 4% from a year ago. British Columbia was down 6.0% from August as it grew 1% a year ago, while Quebec was down 5.2% from August and up 48% from a year ago.
October sales data will be released on December 19.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.
friends,
What a tough month it has been for the cannabis industry so far. While not as bad as last November, the Global Hemp Stock Index is down 16% this month, and at 5.74 it is now down 16.6% year-to-date. I’ve been very cautious with my model portfolio at 420 Investor, which is down 2.6% so far in 2025, and I’ve been cautious here as well.
In August, the market rallied after President Trump said he was considering rescheduling cannabis. There has been no action for more than three months. If cannabis is moved to schedule III, it will disappear 280E tax. I called for it loudly in late 2022 in a newsletter here about essentials for hemp stocks.
I warned in the newsletter after Labor Day that several hemp stocks were in danger of falling significantlyand many have. I shared the Q3 earnings for the 23 stocks that were in the Global Hemp Stock Index at the time. The index now has 28 names, as we detailed back in late September two shares are subtracted and seven are added. In that newsletter from early September, I named 8 stocks that I was very concerned about. Here’s how they’ve performed since then.
While not all of them declined, as Village Farms continued to grow, the remaining seven were down at least 12.3%. The eight stocks I alerted readers to fell an average of 18.6%. The Global Hemp Stock Index fell 17.9%, while the MSOS ETF fell 35.1%. It is now down 21.5% year to date and remains too much of a risk for what it is investing in. In fact, there was redemption yesterday, with outstanding shares down 0.7%. Shares of 187.21 million were still up 43.4% year-to-date, with most of the increase coming in the third quarter.
Here is the full list of Global Hemp Stock Index members and their change in Q4 so far:
The 28 stocks fell an average of 25.3%, which is how much the index has fallen since it’s flat, with an average decline of 28.3%. MSOS is down 37.6% so far in the 4th quarter. The eight stocks I warned about in early September have one gainer, Village Farmers, but the other seven are all down more than the index. I’ve written negative articles on Seeking Alpha about several of these, including RYM, SNDL, and TLRY recently.
In my 420 Investor model portfolio, I currently have four stocks that are down more than 30% in Q4 and have gained in each of the positions this week. As it relates to the eight stocks I invited, I am no longer so negative on one of them (Canopy Growth, which I updated in an article published today looking for Alpha). The hemp sector has been very volatile, but it still appears to be in a bear market despite the huge rally from the lows.
Hemp stocks are crashing, but for many of them for good reasons from my perspective. The industry as a whole faces challenges, and there is no progress on two potential catalysts that I called for here three years ago: the elimination of 280E taxation, and large exchanges starting to list US hemp operators. Investors can make money by investing in the industry if 280E taxation is removed and other opportunities remain for companies outside the MSO space. However, investing in cannabis is quite risky.
Sincerely,
Alan:
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published last week.
Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.
Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada released August retail sales for the country, with Cannabis sales are on the rise up 1.4% from July levels to C$498.7 million. This sequential increase also increased on a daily basis due to the same number of days compared to the previous month. July, originally reported at C$485.0 million, was revised slightly higher to C$491.8 million. August sales were up 0.9% from a year earlier, up from 8.3% in May and 7.5% in June. This was also below the 20.3% growth rate in August 2023 and above the previous lowest annual growth since the start of legalization in September 2024 of -0.9%, and it was significantly down from the 9.1% growth in December. In 2024, total sales grew 4.5% to C$5.39 billion, and in 2025 they are up 4.5% year-to-date.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales rose 4.8% from July and fell 2% from a year ago. Alberta was down 0.1% from July and up 4% from a year ago. British Columbia was up 8.7% from July after a 9% year-over-year increase, while Quebec was down 10.2% from July and 5% from a year ago.
September sales data will be released on November 21.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
